Immunologic Factors: Clinical Trials

2 trials for Immunologic Factors, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 22Completed 2
Phase 11Completed 1

Follow Immunologic Factors: new trials by email Literature Review of Immunologic Factors trials Research Report on Immunologic Factors

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Ad26.ZEBOV, MVA-BN-Filo Vaccination in Children and Adults Previously Vaccinated With Control in the EBOVAC-Salone Study
Ad26.ZEBOV, MVA-BN-Filo - Virus Diseases, Hemorrhagic Fever, Ebola
Phase 2CompletedLondon School of Hygiene and Tropical Medicine1332022-09-192025-05-11
Study of the Immunogenicity, Safety and Tolerability of the Convacell Vaccine.
Subunit recombinant vaccine for the prevention of coronavirus infection, Placebo - COVID-19, Immunologic Factors
Phase 1 / Phase 2CompletedSt. Petersburg Research Institute of Vaccines and Sera1552021-07-192023-08-30

Narrower conditions

COVID-19 (1)  ·  Coronavirus Infections (1)  ·  Filoviridae Infections (1)  ·  Hemorrhagic Fever, Ebola (1)  ·  Hemorrhagic Fevers, Viral (1)  ·  Infections (1)  ·  Mononegavirales Infections (1)  ·  RNA Virus Infections (1)  ·  Respiratory Tract Infections (1)  ·  Virus Diseases (1)

Broader conditions

Coronaviridae Infections (1)  ·  Infections (1)  ·  Lung Diseases (1)  ·  Nidovirales Infections (1)  ·  Pneumonia (1)  ·  Pneumonia, Viral (1)  ·  RNA Virus Infections (1)  ·  Respiratory Tract Diseases (1)  ·  Virus Diseases (1)

Sponsors

London School of Hygiene and Tropical Medicine (1)  ·  St. Petersburg Research Institute of Vaccines and Sera (1)

Countries

Russia (1)  ·  Sierra Leone (1)

Top investigators

Deborah Watson-Jones, PhD (1)